warfarin,acalabrutinib,zanubrutinib,venetoclax,obinutuzumab,ibrutinib
roche,astrazeneca,janssen,abbvie,beigene
[' ibru', 'cll', 'acalabrutinib', 'venetoclax', 'myeloid', 'obinu', 'warfarin', 'zanubrutinib']
excellent session by dr. jennifer brown at #ash22 on important considerations and unanswered questions in selecting frontline tx in #cll. 
Assistant Professor at UNC Eshelman School of Pharmacy. #adherence, #leukemia, #globalhealth, #access, #impsci, #equity